# Hemab Therapeutics Holdings, Inc.: Form S-1/A, filed Apr 27, 2026

- Company: [Hemab Therapeutics Holdings, Inc.](/companies/coag.md) (CIK 2114044)
- Form: S-1/A
- Filed: 2026-04-27
- Accepted by EDGAR: Apr 27, 2026, 07:09 ET
- Period: not reported
- Accession: 0001193125-26-178809
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2114044/000119312526178809/d50309ds1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2114044/000119312526178809/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2114044/000119312526178809/d50309ds1a.htm

Filed Apr 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-178809. Last ingested by Listed: Nov 6, 2026, 12:41 ET. No prices; not investment advice.
